In addition, PPARγ ligands have also been shown to exert anti-angiogenic effects and to decrease VEGF expression in different types of cancers, such as glioblastoma and Lewis lung carcinoma cells [26,27]. Here, PPARG is linked to Carcinoma, Lewis Lung.